» Authors » Patience Moyo

Patience Moyo

Explore the profile of Patience Moyo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 58
Citations 492
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Oganisian A, Girard A, Steingrimsson J, Moyo P
Biometrics . 2024 Dec; 80(4). PMID: 39656742
Observational studies of recurrent event rates are common in biomedical statistics. Broadly, the goal is to estimate differences in event rates under 2 treatments within a defined target population over...
2.
Rosenmoss S, Larochelle M, Bearnot B, Weinstein Z, So-Armah K, Moyo P, et al.
J Addict Med . 2024 Nov; 19(2):165-171. PMID: 39514897
Objectives: The aim of the study was to examine the association between Black, White, and Hispanic or Latino race and ethnicity and referral rejection from private postacute care facilities among...
3.
Moyo P, Anderson J, Francis K, Biles J
J Clin Nurs . 2024 Sep; 33(11):4297-4313. PMID: 39287216
Background: There is increased interest in implementing structured clinical handover frameworks to improve clinical handover processes. Research postulates that structured clinical handover frameworks increase the quality of handovers; yet inconsistencies...
4.
Moyo P, Choudry E, George M, Zullo A, Ritter A, Rahman M
J Am Med Dir Assoc . 2024 Aug; 25(10):105190. PMID: 39117298
Objectives: To investigate disparities in admissions to highly rated skilled nursing facilities (SNFs) between Medicare beneficiaries with and without opioid use disorder (OUD). Design: Nationwide, retrospective observational cohort. Setting And...
5.
Moyo P, Merlin J, Gairola R, Girard A, Shireman T, Trivedi A, et al.
J Gen Intern Med . 2024 Jun; 39(11):2097-2105. PMID: 38829451
Background: Practice guidelines recommend nonpharmacologic and nonopioid therapies as first-line pain treatment for acute pain. However, little is known about their utilization generally and among individuals with opioid use disorder...
6.
Moyo P, Nishar S, Merrick C, Streltzov N, Asiedu E, Roma C, et al.
JAMA Netw Open . 2024 Feb; 7(2):e2354746. PMID: 38315484
Importance: Skilled nursing facilities (SNFs) are being referred more individuals with opioid use disorder (OUD), even when their medical needs are not directly associated with OUD. Objective: To characterize factors...
7.
Choudry E, Rofe K, Konnyu K, Marshall B, Shireman T, Merlin J, et al.
Innov Aging . 2023 Dec; 7(10):igad085. PMID: 38094932
Background And Objectives: Clinical practice guidelines recommend noninvasive nonpharmacological pain therapies; however, reviews that assess the literature pertaining to nonpharmacological pain management among older adults and people with long-term disabilities...
8.
Moyo P, Merlin J, George M, Shireman T, Marshall B
J Pain . 2023 Oct; 25(3):742-754. PMID: 37820847
Nonpharmacologic approaches are recommended as first-line treatment for chronic pain, and their importance is heightened among individuals with co-occurring opioid use disorder (OUD), in whom opioid therapies may be particularly...
9.
Bhondoekhan F, Marshall B, Shireman T, Trivedi A, Merlin J, Moyo P
JAMA Netw Open . 2023 Sep; 6(9):e2333251. PMID: 37698860
Importance: Nonpharmacologic treatments are important for managing chronic pain among persons with opioid use disorder (OUD), for whom opioid and other pharmacologic therapies may be particularly harmful. Racial and ethnic...
10.
Moyo P, Vaillant J, Girard A, Gairola R, Shireman T, Trivedi A, et al.
Drug Alcohol Depend . 2023 Jun; 248:109930. PMID: 37269776
Introduction: Pain treatment guidelines prioritize nonopioid therapies over opioid medications to prevent opioid-related harms. We examined trends in receipt and intensity of nonpharmacologic, nonopioid medication, and opioid therapies among Medicare...